ERVIMMUNE
LIVE

Serial Number

97910441

Owner

ERVIMMUNE

Attorney

Pina Campagna

Filing Date

Apr 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ERVIMMUNE Trademark

Serial Number: 97910441 • Registration: 7444894

ERVIMMUNE is a trademark filed by ERVIMMUNE on April 27, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ERVIMMUNE (3 trademarks)

CENTRE L�ON B�RARD 28 RUE LAENNEC
LYON CEDEX 08 69373 , FR

Entity Type: 99

Ervaccine Technologies (3 trademarks)

Centre Léon Bérard 28 Rue Laennec
Lyon Cedex 08 69373 , FR

Entity Type: 99

Trademark Details

Filing Date

April 27, 2023

Registration Date

July 9, 2024

Goods & Services

Pharmaceutical preparations for the treatment of cancer; therapeutic vaccines; Medical preparations, namely, T-cell therapy preparations for the treatment of cancer; stem cells for medical use; biological preparations for the prevention and treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of cancer; chemical preparations for medical purposes, namely, for the prevention or treatment of cancer; medicinal preparations for the treatment of infectious diseases and for use in immunotherapy and oncology; all aforementioned goods not for use in the field of medical diagnostics

Medical and surgical services in the field of immunotherapy and oncology; medical testing for treatment purposes; provision of medical information in the field of immunotherapy and oncology; medical analysis for the treatment of persons; genetic testing services for medical purposes; all aforementioned services not for use in the field of medical diagnostics

Medical research laboratory services; biotechnological and pharmaceutical drug research and development services; pharmaceutical and biotechnological research and development; provision of medical and scientific research information in the field of pharmaceuticals; provision of medical and scientific research information in the field of therapeutic vaccines; provision of medical and scientific research information in the field of oncology, immunotherapy, stem cell therapy, and T-cell therapy; Providing medical and scientific research information in the field of clinical trials; screening and selection of molecules for scientific and pharmacological research purposes, not for medical purposes; research and development in the field of immunotherapy; all aforementioned services not for use in the field of medical diagnostics

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 6, 2024 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 9, 2024 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Jul 9, 2024 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
May 31, 2024 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 28, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 28, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 4, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 4, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 4, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2024 TEME
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 22, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 25, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 25, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 25, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 24, 2024 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Nov 13, 2023 AMPX
ASSIGNED TO LIE
Nov 13, 2023 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 8, 2023 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 25, 2023 NWOS
NEW APPLICATION ENTERED
May 1, 2023 NWAP